BioCryst Pharmaceuticals Price Target Maintained With a $14.00/Share by Needham

biocryst制药股价目标维持在每股14.00美元，Needham

道琼斯 · 11/05 23:00 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.